Earnings Feed
Start Free
Home/Insiders/Stejbach Mark
SM
SEC Insider//CIK 0001487937

Stejbach Mark

CIK 00014879374 companiesNORTH CHESTERFIELD, VA
SEC Profile

Transactions

50

Companies

4

Filings

8

CIK

0001487937

Recent Transactions

50 trades
  • Purchase
    Indivior Pharmaceuticals, Inc.$INDV

    Ordinary Shares

    2026-01-05$35.39/sh+775→ 16,847 total
  • Disposition to Issuer
    Flexion Therapeutics Inc

    Stock option (right to buy)

    2021-11-19−7,000→ 0 total
  • Disposition to Issuer
    Flexion Therapeutics Inc

    Stock option (right to buy)

    2021-11-19−25,000→ 0 total
  • Disposition to Issuer
    Flexion Therapeutics Inc

    Common Stock

    2021-11-19$8.50/sh−12,631→ 0 total
  • Disposition to Issuer
    Flexion Therapeutics Inc

    Stock option (right to buy)

    2021-11-19−12,500→ 0 total
  • Disposition to Issuer
    Flexion Therapeutics Inc

    Stock option (right to buy)

    2021-11-19−12,500→ 0 total
  • Disposition to Issuer
    Flexion Therapeutics Inc

    Stock option (right to buy)

    2021-11-19−12,500→ 0 total
  • Disposition to Issuer
    Flexion Therapeutics Inc

    Stock option (right to buy)

    2021-11-19−7,000→ 0 total
  • Award
    Flexion Therapeutics Inc

    Common Stock

    2021-06-24+4,500→ 12,631 total
  • Award
    Flexion Therapeutics Inc

    Stock option (right to buy)

    2021-06-24+7,000→ 7,000 total
  • Award
    Flexion Therapeutics Inc

    Stock option (right to buy)

    2020-06-10+7,000→ 7,000 total
  • Award
    Flexion Therapeutics Inc

    Common Stock

    2020-06-10+4,500→ 6,551 total
  • Purchase
    Flexion Therapeutics Inc

    Common Stock

    2020-05-26$9.75/sh+2,051→ 2,051 total
  • Award
    Flexion Therapeutics Inc

    Stock option (right to buy)

    2019-06-19+12,500→ 12,500 total
  • Award
    Flexion Therapeutics Inc

    Stock option (right to buy)

    2018-06-20+12,500→ 12,500 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Restricted Stock Unit Award

    2018-03-03−2,813→ 0 total
  • Tax Payment
    Alkermes plc.$ALKS

    Ordinary Shares

    2018-03-03$60.05/sh−1,251→ 51,065 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Ordinary Shares

    2018-03-03+2,813→ 52,316 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Restricted Stock Unit Award

    2018-03-01−5,250→ 10,500 total
  • Tax Payment
    Alkermes plc.$ALKS

    Ordinary Shares

    2018-03-01$57.41/sh−2,334→ 49,503 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Ordinary Shares

    2018-03-01+5,250→ 51,837 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Ordinary Shares

    2018-02-26+2,625→ 47,754 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Restricted Stock Unit Award

    2018-02-26−2,625→ 2,625 total
  • Tax Payment
    Alkermes plc.$ALKS

    Ordinary Shares

    2018-02-26$58.12/sh−1,167→ 46,587 total
  • Gift
    Alkermes plc.$ALKS

    Ordinary Shares

    2018-02-23−1,000→ 45,129 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Restricted Stock Unit Award

    2018-02-17−3,000→ 9,000 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Ordinary Shares

    2018-02-17+3,000→ 47,013 total
  • Tax Payment
    Alkermes plc.$ALKS

    Ordinary Shares

    2018-02-17$67.26/sh−884→ 46,129 total
  • Award
    Alkermes plc.$ALKS

    Employee Stock Option (Right to Buy)

    2018-02-16+54,500→ 54,500 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Employee Stock Option (Right to Buy)

    2018-02-16−10,880→ 5,780 total
  • Award
    Alkermes plc.$ALKS

    Restricted Stock Unit Award

    2018-02-16+13,500→ 13,500 total
  • Sale
    Alkermes plc.$ALKS

    Ordinary Shares

    2018-02-16$70.50/sh−10,880→ 44,013 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Ordinary Shares

    2018-02-16$17.30/sh+10,880→ 54,893 total
  • Award
    Flexion Therapeutics Inc

    Stock Option (Right to Buy)

    2017-06-22+12,500→ 12,500 total
  • Purchase
    Flexion Therapeutics Inc

    Common Stock

    2017-06-16$17.02/sh+1,580→ 1,580 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Employee Stock Option (Right to Buy)

    2017-06-08−10,000→ 16,660 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Ordinary Shares

    2017-06-08$17.30/sh+10,000→ 54,013 total
  • Sale
    Alkermes plc.$ALKS

    Ordinary Shares

    2017-06-08$60.34/sh−10,000→ 44,013 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Ordinary Shares

    2017-05-28+2,500→ 44,013 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Restricted Stock Unit Award

    2017-05-28−2,500→ 0 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Ordinary Shares

    2017-03-03+2,812→ 41,513 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Restricted Stock Unit Award

    2017-03-03−2,812→ 2,813 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Ordinary Shares

    2017-03-01+5,250→ 41,138 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Restricted Stock Unit Award

    2017-03-01−5,250→ 15,750 total
  • Tax Payment
    Alkermes plc.$ALKS

    Ordinary Shares

    2017-03-01$59.71/sh−2,437→ 38,701 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Ordinary Shares

    2017-02-26+2,625→ 36,740 total
  • Tax Payment
    Alkermes plc.$ALKS

    Ordinary Shares

    2017-02-26$52.98/sh−852→ 35,888 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Restricted Stock Unit Award

    2017-02-26−2,625→ 5,250 total
  • Award
    Alkermes plc.$ALKS

    Restricted Stock Unit Award

    2017-02-17+12,000→ 12,000 total
  • Award
    Alkermes plc.$ALKS

    Employee Stock Option (Right to Buy)

    2017-02-17+50,000→ 50,000 total

Companies

4

Recent Filings

8

Address

10710 MIDLOTHIAN TURNPIKE SUITE 125

NORTH CHESTERFIELD, VA, 23235

View on SEC.gov